Lynn Fischer

Chief Executive Officer • TITLE21 Health Solutions

Lynn Fischer, M.B.A., has over 25 years’ experience in Strategy, General Management and Marketing in leadership positions. Lynn serves as CEO of Title21 Health Solutions, an innovative software company delivering highly configurable, integrated solutions to help health care and life science companies gain regulatory compliance, reduce costs, improve quality and achieve a paperless environment. Her strategic initiatives have led Title21 to become the end-to-end solution for integrated data management in health sciences. Lynn has also led this technology firm’s new product innovation into cord blood, cellular therapy, and biotech to support improvement in patient quality, safety and care.

Lynn previously held the position of Vice President of Sales and Marketing at Title21. Her prior career experience includes being General Manager of the M&M/Mars and Dreyer’s/Edy’s Grand Ice Cream Joint Venture. Ms. Fischer also repositioned and launched Concannon Vineyards nationally as Vice-President of Marketing of The Wine Group, the world’s third largest winery. Lynn launched her marketing career at E. & J. Gallo Winery growing the Canadian wine business after graduating from the Katz Graduate School of Business at the University of Pittsburgh in Strategic Planning and Marketing. Her passion is to develop and deliver innovative technologies that improve patient quality and the overall healthcare experience.

Also Speaking

Serene Forte

Senior Vice President and Head of Genetic Medicine • RELIEF Therapeutics

Tony Wells

CEO • Merit

Leonardo M.R. Ferreira

Assistant Professor of Microbiology and Immunology  • Medical University of South Carolina

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.